Literature DB >> 20859958

Achievements and perspectives of top-down proteomics.

Andrea Armirotti1, Gianluca Damonte.   

Abstract

Over the last years, top-down (TD) MS has gained a remarkable space in proteomics, rapidly trespassing the limit between a promising approach and a solid, established technique. Several research groups worldwide have implemented TD analysis in their routine work on proteomics, deriving structural information on proteins with the level of accuracy that is impossible to achieve with classical bottom-up approaches. Complete maps of PTMs and assessment of single aminoacid polymorphisms are only a few of the results that can be obtained with this technique. Despite some existing technical and economical limitations, TD analysis is at present the most powerful instrument for MS-based proteomics and its implementation in routine workflow is a rapidly approaching turning point in proteomics. In this review article, the state-of-the-art of TD approach is described along with its major advantages and drawbacks and the most recent trends in TD analysis are discussed. References for all the covered topics are reported in the text, with the aim to support both newcomers and mass spectrometrists already introduced to TD proteomics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859958     DOI: 10.1002/pmic.201000245

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  22 in total

1.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

Review 2.  The emerging role of native mass spectrometry in characterizing the structure and dynamics of macromolecular complexes.

Authors:  Elisabetta Boeri Erba; Carlo Petosa
Journal:  Protein Sci       Date:  2015-03-31       Impact factor: 6.725

Review 3.  Top-down proteomics in health and disease: challenges and opportunities.

Authors:  Zachery R Gregorich; Ying Ge
Journal:  Proteomics       Date:  2014-05       Impact factor: 3.984

Review 4.  Progress in Top-Down Proteomics and the Analysis of Proteoforms.

Authors:  Timothy K Toby; Luca Fornelli; Neil L Kelleher
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2016-06-12       Impact factor: 10.745

5.  Top-Down Proteomics Reveals Myofilament Proteoform Heterogeneity among Various Rat Skeletal Muscle Tissues.

Authors:  Jake A Melby; Yutong Jin; Ziqing Lin; Trisha Tucholski; Zhijie Wu; Zachery R Gregorich; Gary M Diffee; Ying Ge
Journal:  J Proteome Res       Date:  2019-11-07       Impact factor: 4.466

Review 6.  Comprehensive analysis of protein modifications by top-down mass spectrometry.

Authors:  Han Zhang; Ying Ge
Journal:  Circ Cardiovasc Genet       Date:  2011-12

7.  Online Hydrophobic Interaction Chromatography-Mass Spectrometry for Top-Down Proteomics.

Authors:  Bifan Chen; Ying Peng; Santosh G Valeja; Lichen Xiu; Andrew J Alpert; Ying Ge
Journal:  Anal Chem       Date:  2016-01-14       Impact factor: 6.986

Review 8.  Top-down mass spectrometry: recent developments, applications and perspectives.

Authors:  Weidong Cui; Henry W Rohrs; Michael L Gross
Journal:  Analyst       Date:  2011-08-08       Impact factor: 4.616

9.  Ultrahigh pressure fast size exclusion chromatography for top-down proteomics.

Authors:  Xin Chen; Ying Ge
Journal:  Proteomics       Date:  2013-07-30       Impact factor: 3.984

Review 10.  Identification and Quantification of Proteoforms by Mass Spectrometry.

Authors:  Leah V Schaffer; Robert J Millikin; Rachel M Miller; Lissa C Anderson; Ryan T Fellers; Ying Ge; Neil L Kelleher; Richard D LeDuc; Xiaowen Liu; Samuel H Payne; Liangliang Sun; Paul M Thomas; Trisha Tucholski; Zhe Wang; Si Wu; Zhijie Wu; Dahang Yu; Michael R Shortreed; Lloyd M Smith
Journal:  Proteomics       Date:  2019-05       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.